Case 3: Results of the IMpassion130 Trial in Metastatic Breast Cancer Targeted Oncology 6:33 4 years ago 213 Далее Скачать
Results from the IMpassion 130 trial treating metastatic breast cancer ecancer 4:56 5 years ago 316 Далее Скачать
Results from the IMpassion130 trial for triple-negative breast cancer ecancer 4:53 5 years ago 182 Далее Скачать
The IMpassion130 Trial in Metastatic Triple-Negative Breast Cancer Targeted Oncology 1:16 4 years ago 296 Далее Скачать
Case 3: Atezolizumab/Nab-Paclitaxel for Triple Negative Breast Cancer Targeted Oncology 5:45 4 years ago 388 Далее Скачать
Case 3: Metastatic Triple-Negative Breast Cancer Targeted Oncology 2:26 4 years ago 4 027 Далее Скачать
Debu Tripathy, MD, elaborates on outcomes from the ImPassion130 trial OBRoncology 1:44 5 years ago 41 Далее Скачать
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer ecancer 5:59 3 years ago 152 Далее Скачать
IMpassion130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC Targeted Oncology 0:59 5 years ago 153 Далее Скачать
Joyce O’Shaughnessy, MD, shares results of the Impassion130 trial presented at ESMO 2019 OBRoncology 1:09 4 years ago 28 Далее Скачать
IMpassion130: results of atezolizumab plus nab-paclitaxel for frontline TNBC VJOncology 7:08 5 years ago 1 234 Далее Скачать
Case 3: Treatment After Progression in Triple-Negative Breast Cancer Targeted Oncology 5:54 4 years ago 584 Далее Скачать
